Clinical Context
A 52-year-old adult with a family history of premature coronary artery disease and elevated lifetime cardiovascular risk requests genomic risk assessment. The clinician orders the CardioRisk+ proprietary test to quantify polygenic susceptibility to acquired heart disease. The patient presents to an outpatient clinic or a certified phlebotomy center; a buccal (cheek) swab sample is collected per manufacturer instructions, demographic and lifestyle data (smoking status, BMI, diet, physical activity) and relevant clinical data (personal history of hypertension, hyperlipidemia, diabetes, current medications) are recorded and securely transmitted to the testing laboratory (Gene by Gene Ltd. / OpenDNA Ltd.). The laboratory performs DNA extraction, genotyping, and an algorithmic analysis that integrates genomic markers with the supplied lifestyle and clinical variables to produce a polygenic risk score for acquired heart disease. Test results are returned to the ordering clinician with an interpretation report indicating relative genetic risk compared to population norms. Typical sites of service include outpatient primary care clinics, cardiology clinics, preventive medicine clinics, and certified laboratory specimen collection centers. Billing uses the PLA code 0466U to report the CardioRisk+ test. Common clinical uses include risk stratification discussions, shared decision-making about preventive strategies, and informing consideration of early lifestyle or pharmacologic interventions.
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|
0466U | CardioRisk+ (proprietary PLA): DNA analysis from buccal swab integrated with lifestyle and clinical data to report polygenic risk for acquired heart disease | Principal billing code for the CardioRisk+ test; used by the performing lab (Gene by Gene Ltd. / OpenDNA Ltd.). |
99000 | Handling and/or conveyance of specimen for transfer from physician's office to a laboratory | May be billed by some providers or courier services when specimens are transported to the performing laboratory (billing practices vary by payer).
36415 | Collection of venous blood by venipuncture | Not typically required for buccal swab testing; included when additional blood tests are ordered same visit for complementary risk assessment (lipid panel, glucose).
81002 | Urinalysis, non-automated, without microscopy | Example of common ancillary tests performed during cardiovascular risk evaluation visit; not directly related to the PLA but often part of the overall assessment.
83036 | Hemoglobin; glycosylated (A1C) | Common companion laboratory test for assessing cardiometabolic risk performed before or after genetic risk testing.
80061 | Lipid panel (total, HDL, LDL, triglycerides) | Frequently ordered alongside genetic risk testing to provide current biochemical cardiovascular risk data that complements polygenic risk results.